IFNA1 and neoplasm: While further mechanistic studies are required to draw this conclusion, our current findings that repeat RNA-enriched tumor-derived EVs can induce IFN-response genes in human primary monocytic cells and a macrophage cell line suggest a direct mechanism for repeat RNA modulation of the tumor immune microenvironment.